Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

317
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
317
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

958
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
958
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.5K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

100
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
100
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

562
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
562
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

2.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of IBS-associated E. coli strains with epithelial inflammatory responses and tight junction dysregulation in Caco-2 cells.

BMC research notes·2026
Same author

Antimicrobial Photodynamic Therapy With New Methylene Blue and Its Combined Effect With Antibiotics Against MDR Acinetobacter baumannii.

MicrobiologyOpen·2026
Same author

Fecal Microbiome Alterations in Colorectal Cancer: A Systematic Review of Compositional Changes and Microbial Biomarkers.

MicrobiologyOpen·2026
Same author

Comparison of eating behaviors between single-child and child with siblings: an analytical cross-sectional study.

BMC pediatrics·2026
Same author

The Effect of <i>Moringa oleifera</i> on Body Weight and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Food science & nutrition·2026
Same author

Investigating the relationship between energy-adjusted dietary inflammatory index with anthropometric indices, clinical symptoms, inflammatory markers, sleep quality and quality of life in patients with rheumatoid arthritis: a cross-sectional study.

BMC nutrition·2026
Same journal

Aztreonam-Avibactam and Cefiderocol against Metallo-β-Lactamase-Producing Enterobacterales and Other Carbapenem-Resistant Gram-Negative Pathogens: Microbiological Activity and Clinical Evidence.

Journal of global antimicrobial resistance·2026
Same journal

Genomic characterization of antimicrobial resistance genes, mobile genetic elements, sequence types and serotypes of Escherichia coli derived from water buffalo in Italy.

Journal of global antimicrobial resistance·2026
Same journal

Genome-confirmed Pluralibacter gergoviae urinary tract infection in a companion animal in Peru.

Journal of global antimicrobial resistance·2026
Same journal

Prevalence of mcr-positive Enterobacterales and characterization of mcr-9-carrying plasmids from pig farm ecosystems in Fujian, China.

Journal of global antimicrobial resistance·2026
Same journal

Genomic Insights into the Transmission Dynamics and Virulence of Carbapenem-Resistant Klebsiella pneumoniae in the ICU: A Retrospective Cohort Study.

Journal of global antimicrobial resistance·2026
Same journal

Characterization of a multidrug-resistant hypervirulent ST367-KL1 Klebsiella quasipneumoniae subsp. similipneumoniae strain harboring bla<sub>CTX-M-14</sub> plasmid.

Journal of global antimicrobial resistance·2026
See all related articles

Related Experiment Video

Updated: Nov 14, 2025

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

12.2K

Bedaquiline: Current status and future perspectives.

Saeed Khoshnood1, Mehdi Goudarzi2, Elahe Taki3

  • 1Clinical MicrobiologyResearch Center, Ilam University of Medical Sciences, Ilam, Iran.

Journal of Global Antimicrobial Resistance
|March 8, 2021
PubMed
Summary
This summary is machine-generated.

Drug-resistant tuberculosis (TB) is a growing global health crisis. Bedaquiline (BDQ) shows promise as a new therapy for drug-resistant TB, with ongoing research into its resistance patterns and clinical applications.

Keywords:
BedaquilineMultidrug resistanceMycobacterium tuberculosisTuberculosis

More Related Videos

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

1.2K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.1K

Related Experiment Videos

Last Updated: Nov 14, 2025

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

12.2K
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

1.2K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.1K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Drug-resistant tuberculosis (TB) poses a significant global health threat, with over 500,000 new cases annually.
  • Increasing rates of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) necessitate novel therapeutic strategies.
  • Existing treatments for TB are becoming less effective due to widespread drug resistance.

Purpose of the Study:

  • To review current data on bedaquiline (BDQ) resistance in Mycobacterium tuberculosis.
  • To describe the antimicrobial properties of BDQ against susceptible and resistant TB strains.
  • To explore new perspectives on the clinical utility of BDQ for TB treatment.

Main Methods:

  • Narrative review of existing scientific literature.
  • Analysis of data on bedaquiline's minimum inhibitory concentrations (MICs).
  • Synthesis of information regarding BDQ resistance mechanisms and clinical outcomes.

Main Results:

  • Bedaquiline (BDQ) demonstrates potent activity against both drug-susceptible and drug-resistant TB strains.
  • BDQ has been recently approved for the treatment of multidrug-resistant TB (MDR-TB).
  • Data on BDQ resistance is emerging, highlighting the need for careful monitoring.

Conclusions:

  • Bedaquiline (BDQ) represents a crucial new option for managing drug-resistant tuberculosis (TB).
  • Understanding and monitoring BDQ resistance is essential for maintaining its long-term efficacy.
  • Further research into BDQ's clinical application will optimize its use in TB therapy.